Price (delayed)
$15.12
Market cap
$400.57M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$5.56
Enterprise value
$253.85M
Founded in 2013 and based in San Diego, California, Arcturus Therapeutics Holdings Inc. is a clinical-stage mRNA medicines and vaccines company with enabling technologies: (i) LUNAR® lipid-mediated delivery, (ii) STARR™
There are no recent dividends present for ARCT.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.